Edaravone injection reverses learning and memory deficits in a rat model of vascular dementia
Authors:
- 1 January 2017
- journal article
- research article
- Published by China Science Publishing & Media Ltd. in Acta Biochimica et Biophysica Sinica
- Vol. 49 (1) , 83-89
Abstract
Edaravone is a novel free radical scavenger that exerts neuroprotective effects by inhibiting endothelial injury and by ameliorating neuronal damage in brain ischemia. Recently, it was reported that edaravone could alleviate the pathology and cognitive deficits of Alzheimer's disease patients. However, its relevance to vascular dementia (VaD) is not clear. In this study, we partially occluded the bilateral carotid arteries of rats surgically to induce chronic cerebral hypoperfusion (CCH), a well-known rat model of VaD. Water maze and step-down inhibitory test were used to evaluate the memory deficit. The activities of superoxide dismutase (SOD) and lactate dehydrogenase (LDH), the content of malondialdehyde (MDA) and total reactive oxygen species were measured to evaluate the oxidative stress level. Western blot analysis was used to evaluate the synaptic protein expression. It was found that treatment with edaravone for a 5-week period was able to reverse both spatial and fear-memory deficits in rats with CCH. Edaravone significantly reduced the level of oxidative stress in the brains of rats with CCH by increasing SOD activity and decreasing the content of MDA, LDH, and total reactive oxygen species. Furthermore, edaravone treatment also restored the levels of multiple synaptic proteins in the hippocampi of rats with CCH. Our data provide direct evidence supporting the neuroprotective effects of edaravone in VaD. We propose that the alleviation of oxidative stress and restoration of synaptic proteins play important roles in neuroprotection.Keywords
Funding Information
- key scientific and technological projects of Henan Province (122102310072, 122102310155)
- Scientific and Technological Projects of Zhengzhou (121PPTGG492-4, 121PPTGG492-5)
This publication has 33 references indexed in Scilit:
- Neurohistological and behavioral changes following the four-vessel occlusion/internal carotid artery model of chronic cerebral hypoperfusion: Comparison between normotensive and spontaneously hypertensive ratsBehavioural Brain Research, 2013
- Epidemiology of Alzheimer's disease and other forms of dementia in China, 1990–2010: a systematic review and analysisThe Lancet, 2013
- Vascular Cognitive Disorder. A Biological and Clinical OverviewNeurochemical Research, 2010
- Phospholipase A2, reactive oxygen species, and lipid peroxidation in CNS pathologiesBMB Reports, 2008
- Permanent, bilateral common carotid artery occlusion in the rat: A model for chronic cerebral hypoperfusion-related neurodegenerative diseasesBrain Research Reviews, 2007
- Neuroprotective Effects of Edaravone: a Novel Free Radical Scavenger in Cerebrovascular InjuryCNS Drug Reviews, 2006
- Chronic Mild Reduction of Cerebral Perfusion Pressure Induces Ischemic Tolerance in Focal Cerebral IschemiaStroke, 2005
- Risk factors for cerebral hypoperfusion, mild cognitive impairment, and dementiaNeurobiology of Aging, 2000
- The question of familial meningiomas and schwannomas:Neurology, 2000
- Progressive cognitive impairment following chronic cerebral hypoperfusion induced by permanent occlusion of bilateral carotid arteries in ratsBrain Research, 1994